FindTrial
Sign In

TRAMADOL VERSUS TAPENTADOL POSTOPERATIVE PAIN MANAGEMENT

COMPARISION OF SAFETY AND EFFICACY OF TRAMADOL VERSUS TAPENTADOL ON POST OPERATIVE PAIN MANAGEMENT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046753
Enrollment
50
Registered
2022-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: T.TAPENTADOL: T.TAPENTADOL 50Mg (1-0-1)will be administered in postop period once patients have been started with oral feeds and the parentral analgesics will be discontinued or SOS.Tim

Sponsors

Dr MURUGANAND M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing open hernia surgeries

Exclusion criteria

Exclusion criteria: Age less than 18 years Allergy to opiates Renal failure(creatinine more than 2mg per dl Respiratory allergy/asthma Hepatic failure Comorbid alcohol,opiod or other substance abuse disorder

Design outcomes

Primary

MeasureTime frame
Severity of post operative pain using visual analogue scoreTimepoint: 0,1,4,12,24 hours—

Secondary

MeasureTime frame
Incidence and severity of side effectsTimepoint: 1st,4th,12th and 24th hours—

Countries

India

Contacts

Public ContactDr AATHIRA UDAYAKUMAR

PSG INSTITUTE OF MEDICAL SCIENCES AND RESEARCH

aathiranair.uk1996@gmail.com9442132340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026